An open-label study of AZD0120 in adults with multiple sclerosis

Trial Identifier: D831DC00001
Sponsor: AstraZeneca
Start Date: December 2025
Primary Completion Date: December 2028
Study Completion Date: December 2028
Condition: Multiple Sclerosis (MS)

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
US, AZ Tucson, AZ, US, 85719
US, CO Aurora, CO, US, 80045
US, DC Washington, DC, US, 20007
US, MO Saint Louis, MO, US, 63110
US, NY New York, NY, US, 10032
US, NY New York, NY, US, 10016
US, OH Cleveland, OH, US, 44195
US, WA Seattle, WA, US, 98104
US, WI Milwaukee, WI, US, 53226